| Comparison of weighting methods used in multicriteria decision analysis frameworks in healthcare with focus on low-and middle-income countries B Németh, A Molnár, S Bozóki, K Wijaya, A Inotai, JD Campbell, Z Kaló Journal of comparative effectiveness research 8 (4), 195-204, 2019 | 145 | 2019 |
| Quality-adjusted life year difference in patients with predominant negative symptoms of schizophrenia treated with cariprazine and risperidone B Németh, A Molnár, R Akehurst, M Horváth, K Kóczián, G Németh, ... Journal of comparative effectiveness research 6 (8), 639-648, 2017 | 44 | 2017 |
| A systematic review of the indirect costs of schizophrenia in Europe A Fasseeh, B Németh, A Molnár, FU Fricke, M Horváth, K Kóczián, ... European journal of public health 28 (6), 1043-1049, 2018 | 42 | 2018 |
| Guidance toward the implementation of multicriteria decision analysis framework in developing countries A Inotai, HT Nguyen, B Hidayat, T Nurgozhin, PHT Kiet, JD Campbell, ... Expert review of pharmacoeconomics & outcomes research 18 (6), 585-592, 2018 | 39 | 2018 |
| A systematic review of health economic models and utility estimation methods in schizophrenia B Németh, A Fasseeh, A Molnár, I Bitter, M Horváth, K Kóczián, Á Götze, ... Expert review of pharmacoeconomics & outcomes research 18 (3), 267-275, 2018 | 37 | 2018 |
| Development of multi-criteria decision analysis (MCDA) framework for off-patent pharmaceuticals–an application on improving tender decision making in Indonesia A Inotai, D Brixner, N Maniadakis, I Dwiprahasto, E Kristin, A Prabowo, ... BMC health services research 18 (1), 1-12, 2018 | 30 | 2018 |
| Cost‐effectiveness of alternative smoking cessation scenarios in Spain: results from the EQUIPTMOD M Trapero‐Bertran, C Muñoz, K Coyle, D Coyle, A Lester‐George, R Leidl, ... Addiction 113, 65-75, 2018 | 27 | 2018 |
| Development and application of an economic model (EQUIPTMOD) to assess the impact of smoking cessation K Coyle, D Coyle, A Lester‐George, R West, B Nemeth, M Hiligsmann, ... Addiction, 2017 | 26 | 2017 |
| Drug Policy in Central Eastern Europe—Hungary A Inotai, M Csanádi, A Harsányi, B Németh Value in health regional issues 13, 16-22, 2017 | 19 | 2017 |
| Overview on the current implementation of health technology assessment in the healthcare system in Hungary B Németh, M Csanádi, Z Kaló International journal of technology assessment in health care 33 (3), 333-338, 2017 | 19 | 2017 |
| The transferability of health technology assessment: the European perspective with focus on central and Eastern European countries B Németh, W Goettsch, FB Kristensen, O Piniazhko, M Huić, T Tesař, ... Expert Review of Pharmacoeconomics & Outcomes Research 20 (4), 321-330, 2020 | 18 | 2020 |
| Health Technology Assessment Implementation in Ukraine: Current Status and Future Perspectives M Csanádi, A Inotai, O Oleshchuk, O Lebega, B Alexandra, O Piniazhko, ... International journal of technology assessment in health care 35 (5), 393-400, 2019 | 18 | 2019 |
| Evidence requirements for reimbursement of pharmaceuticals across Europe O Oyebode, Z Garrett, E George, A Cangini, LAA Muscolo, S Warren, ... International journal of technology assessment in health care 31 (1-2), 59-67, 2015 | 16 | 2015 |
| Criteria and scoring functions used in multi-criteria decision analysis and value frameworks for the assessment of rare disease therapies: a systematic literature review T Zelei, ND Mendola, B Elezbawy, B Németh, JD Campbell PharmacoEconomics-open 5 (4), 605-612, 2021 | 15 | 2021 |
| Barriers to Use Artificial Intelligence Methodologies in Health Technology Assessment in Central and East European Countries K Tachkov, A Zemplenyi, M Kamusheva, M Dimitrova, P Siirtola, J Pontén, ... Frontiers in Public Health, 2170, 2022 | 13 | 2022 |
| Cost‐effectiveness of increasing the reach of smoking cessation interventions in Germany: results from the EQUIPTMOD MB Huber, M Präger, K Coyle, D Coyle, A Lester‐George, ... Addiction 113, 52-64, 2018 | 13 | 2018 |
| Potential Criteria for Frameworks to Support the Evaluation of Innovative Medicines in Upper Middle-Income Countries—A Systematic Literature Review on Value Frameworks and … I Jakab, B Nemeth, B Elezbawy, MA Karadayı, H Tozan, S Aydın, J Shen, ... Frontiers in pharmacology 11, 1203, 2020 | 12 | 2020 |
| European cooperation in health technology assessment implementation: the perspective of Central and Eastern European countries B Németh, Z Kaló Journal of Comparative Effectiveness Research 9 (9), 599-602, 2020 | 11 | 2020 |
| Cost‐effectiveness of possible future smoking cessation strategies in Hungary: results from the EQUIPTMOD B Németh, J Józwiak‐Hagymásy, G Kovács, A Kovács, T Demjén, ... Addiction 113, 76-86, 2018 | 11 | 2018 |
| Cost-utility analysis of cariprazine compared to risperidone among patients with negative symptoms of schizophrenia B Németh, R Bendes, B Nagy, Á Götze, K Kóczián, M Horváth, I Deák, ... Health Policy and Technology 8 (1), 84-91, 2019 | 10 | 2019 |
